Your browser doesn't support javascript.
loading
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison.
van Steen, Cécile; Celico, Lorenzo; Spaepen, Erik; Hagenacker, Tim; Meuth, Sven G; Ruck, Tobias; Smith, A Gordon; Bodicoat, Danielle H; de Francesco, Maria; Iannazzo, Sergio.
Affiliation
  • van Steen C; Argenx BV, 9052, Zwijnaarde (Ghent), Belgium. cvansteen93@gmail.com.
  • Celico L; HEOR Value Hub, Brussels, Belgium.
  • Spaepen E; HEOR Value Hub, Brussels, Belgium.
  • Hagenacker T; University Medicine Essen, 45147, Essen, Germany.
  • Meuth SG; University Hospital Düsseldorf, 40225, Düsseldorf, Germany.
  • Ruck T; University Hospital Düsseldorf, 40225, Düsseldorf, Germany.
  • Smith AG; VCU Department of Neurology, Richmond, VA, USA.
  • Bodicoat DH; HEOR Value Hub, Brussels, Belgium.
  • de Francesco M; HEOR Value Hub, Brussels, Belgium.
  • Iannazzo S; Argenx BV, 9052, Zwijnaarde (Ghent), Belgium.
Adv Ther ; 41(6): 2486-2499, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38642198

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Cholinergic / Antibodies, Monoclonal, Humanized / Myasthenia Gravis Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Cholinergic / Antibodies, Monoclonal, Humanized / Myasthenia Gravis Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2024 Document type: Article Affiliation country: Country of publication: